VANCOUVER, Feb. 28, 2018 /CNW/ – Harvest One Cannabis Inc. (TSXV:HVT) (“Harvest One” or the “Company”) through its wholly-owned subsidiary United Greeneries (“United Greeneries” or “UG”) is pleased to announce the launch of its retail platform and initial sales of their two brands Royal High and Captain’s Choice.
As previously announced on January 8, 2018, United Greeneries has launched medical sales in February 2018. The fully developed branding was released earlier this week and the fully functional e-commerce platform is currently online. Please visit United Greeneries website at www.unitedgreeneries.com for further information on our products.
United Greeneries signature product line Captain’s Choice™ consists of blended, high-quality ground flowers. Captain’s Choice™ will be available in the varieties “Indica”, “Sativa” and “High-CBD”. United Greeneries’ specialized blending and grinding process results in consistent product quality and reduced production costs that the Company will be passing on to its customers.
The Company’s premium brand Royal High™ will feature prime quality full cannabis flowers of selected varieties, initially consisting of Serious Kush, Great White Shark, Super Skunk, 8 Ball Kush, CBD Tonic, Serious Kush, Northern Lights and Chocolope. Several other varieties are currently in production.
About Harvest One Cannabis Inc. (TSXV: HVT)
Harvest One is a global cannabis company focused on delivering high quality, innovative cannabis products and technology to regulated markets around the world. Our shareholders have significant exposure to the entire cannabis value chain through three business units, with Harvest One serving as the parent company over horticultural arm United Greeneries and medical arm Satipharm AG. Harvest One’s businesses are all strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has a Canadian ACMPR cultivation and sales license, making Harvest One a unique global company with the capacity to commercially cultivate and sell medicinal grade cannabis in a federally regulated environment.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.